Royalty Pharma to pay up to $950 million for royalties from Amgen’s lung cancer drug
(Reuters) -Royalty Pharma has agreed to buy a royalty interest in Amgen's drug for small cell lung cancer from BeOne ...
Read moreDetails(Reuters) -Royalty Pharma has agreed to buy a royalty interest in Amgen's drug for small cell lung cancer from BeOne ...
Read moreDetails
